Ionis Pharmaceuticals IONS Debt Securities Available For Sale And Equity Securities Fv Ni Gross Unrealized Gain
Debt Securities Available For Sale And Equity Securities Fv Ni Gross Unrealized Gain at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiGrossUnrealizedGain.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni gross unrealized gain.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni gross unrealized gain?
- Ionis Pharmaceuticals (IONS) reported debt securities available for sale and equity securities fv ni gross unrealized gain of $66.78M in Q1 2026.
- How has Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni gross unrealized gain changed year-over-year?
- Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni gross unrealized gain increased by 142.5% year-over-year, from $27.54M to $66.78M.
- What is the long-term trend for Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni gross unrealized gain?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's debt securities available for sale and equity securities fv ni gross unrealized gain has grown at a 19.1% compound annual growth rate (CAGR), from $24.52M to $58.65M.
- What does debt securities available for sale and equity securities fv ni gross unrealized gain mean?
- The total paper profit across all debt and equity investments.
- How do you interpret debt securities available for sale and equity securities fv ni gross unrealized gain?
- An increase indicates strong performance across the company's investment portfolio, contributing to higher book value.
- How does debt securities available for sale and equity securities fv ni gross unrealized gain compare across companies?
- A high-level indicator of investment portfolio health compared to industry benchmarks.